ATS 2025 Insights: Axatilimab in Patients With Lung Chronic Graft-versus-host Disease and Related Bronchiolitis Obliterans Syndrome: Results From the AGAVE-201 Study
ATS 2025 Insights: Axatilimab in Patients With Lung Chronic Graft-versus-host Disease and Related Bronchiolitis Obliterans Syndrome: Results From the AGAVE-201 Study
81 views9 months ago
vumedi.com
Safety Analysis of Axatilimab in Patients with Chronic Graft-Versus-Host Disease in an Expanded Access Program | OncLive
Safety Analysis of Axatilimab in Patients with Chronic Graft-Versus-Host Disease in an Expanded Access Program | OncLive
4 months ago
onclive.com
Scenario 2: Belumosudil and Axatilimab as Treatment Options in cGVHD | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Scenario 2: Belumosudil and Axatilimab as Treatment Options in cGVHD | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Apr 4, 2022
targetedonc.com
Safety and Efficacy of Axatilimab in Patients With Chronic Graft-Versus-Host Disease (AGAVE-201) | OncLive
18:08
Safety and Efficacy of Axatilimab in Patients With Chronic Graft-Versus-Host Disease (AGAVE-201) | OncLive
Mar 15, 2024
onclive.com
Dr Kitko on Clinical Outcomes With Axatilimab According to Prior Lines of Therapy for Chronic GVHD | OncLive
Dr Kitko on Clinical Outcomes With Axatilimab According to Prior Lines of Therapy for Chronic GVHD | OncLive
Feb 27, 2025
onclive.com
Incyte und Syndax Pharmaceuticals kündigen die FDA-Zulassung von Niktimvo? (axatilimab-csfr) für die Behandlung der chronischen Graft-Versus-Host Disease (GVHD)
Incyte und Syndax Pharmaceuticals kündigen die FDA-Zulassung von Niktimvo? (axatilimab-csfr) für die Behandlung der chronischen Graft-Versus-Host Disease (GVHD)
Aug 14, 2024
marketscreener.com
NIKTIMVO™ (axatilimab-csfr) - chronic graft-versus-host disease (cGVHD)
1:27
NIKTIMVO™ (axatilimab-csfr) - chronic graft-versus-host disease (cGVHD)
1.3K viewsSep 9, 2024
YouTubePharmacy Talk USA
9:34
Emerging Agents in GVHD: Axatilimab | OncLive
Feb 22, 2024
onclive.com
2:33
New treatments for chronic GVHD are needed. Axatilimab, a monoclonal antibody, may attenuate the inflammation and fibrosis behind GVHD. Research findings are summarized in a new Quick Take video. https://nej.md/3Zpi8sw | The New England Journal of Medicine
1.1K viewsSep 22, 2024
FacebookThe New England Journal of Medicine
Targeting cGVHD: Mechanism of Action of Axatilimab Compared to Other Available Agents
96 viewsOct 14, 2024
vumedi.com
Axatilimab in cGVHD: Mechanism of Action and Comparison With Current Therapeutic Agents
158 viewsNov 10, 2024
vumedi.com
3:39
Clinical outcomes among patients with chronic GvHD treated with axatilimab
26 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
0:43
NIKTIMVO™ (axatilimab-csfr) injection, for intravenous use
76 viewsSep 4, 2024
YouTubeBrimstoneK
Real-World Tolerability and Safety Results for Axatilimab in cGVHD | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
4 months ago
targetedonc.com
The Role of Axatilimab in Targeting CSF1R for Inflammation and Fibrosis in cGVHD – Recently FDA Approved
Sep 7, 2024
vumedi.com
Michael Cramer on Instagram: "Treatment day 11 of the clinical trial! ECP and immunotherapy ( axatilimab today ) #cancersurvivor #chronicgvhd #gvhd #trial #clinicaltrial #hope"
24K views11 months ago
Instagrammichaelreidcramer
Knight Therapeutics Announces Regulatory Submission Of Axatilimab In Brazil
3 months ago
marketscreener.com
21:35
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
2.9K viewsOct 15, 2024
YouTubeOncBrothers: Practice-Changing Cancer Discu…
6:29
FDA Approves Treatment for Chronic Graft Versus Host Disease
564 viewsSep 3, 2024
YouTubeCheckRare
10:33
Daniel Wolff, MD: Safety and Efficacy of Axatilimab in Patients with Chronic GVHD
853 viewsDec 19, 2023
YouTubeAmerican Society of Hematology
1:43
New treatment for chronic GVHD
503 viewsNov 19, 2024
YouTubeQIMR Berghofer
1:22
ASH23: Corey Cutler, MD, MPH, on AGAVE-201 | Dana-Farber Cancer Institute
246 viewsJan 9, 2024
YouTubeDana-Farber Cancer Institute
1:04
Treatment number 190 of extra corporeal photopheresis! Clinical trial continues, getting ECP and axatilimab today! #cancersurvivor #gvhd | Surf
74.5K views7 months ago
FacebookSurf
1:34
What is Graft Versus Host Disease? | Dana-Farber Cancer Institute
4.4K viewsFeb 17, 2023
YouTubeDana-Farber Cancer Institute
Insights Into Real-World Evidence in Chronic GVHD | OncLive
7 months ago
onclive.com
8:32
Axitinib: Unraveling its Mechanism of Action, Life-Changing Uses, and Side Effects
882 viewsOct 7, 2023
YouTubeInevid
2:40
Axitinib Tablet Explained — Uses, Dosage, Mechanisms, Side Effects & Safety Tips | MediInsights
25 views3 months ago
YouTubeMediInsights
16:34
Closing the Treatment Gap in Acute and Chronic GVHD: Post-HCT Innovative Targeted Approaches
450 viewsMar 20, 2024
YouTubePeerView CME
10:18
說文解泌探頭頸-談腎癌標靶藥物Axitinib用藥注意事項
96 viewsMay 1, 2021
YouTube癌症新觀點
1:22:00
Rising to the GVHD Challenge
39 views4 months ago
YouTubePeerView Oncology
See more
Static thumbnail place holder